LH on GnRH-ant day to basal LH affects the IVF/ICSI outcome of PCOS women undergoing GnRH-antagonist protocol

被引:0
作者
Wei, Yi [1 ]
Luan, Ting [2 ]
Shen, Jingjing [1 ]
Zhang, Juanjuan [1 ]
Zhang, Juan [1 ]
Su, Yan [1 ]
Ling, Xiufeng [1 ]
Li, Xin [1 ]
Zhao, Chun [1 ,3 ]
机构
[1] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Reprod Med, Womens Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Obstet & Gynecol, Womens Hosp, Nanjing, Peoples R China
[3] Nanjing Maternal & Child Hlth Hosp, 123 Tianfei Lane, Nanjing 210000, Peoples R China
关键词
controlled ovarian hyperstimulation; GnRH antagonist protocol; in vitro fertilization; luteinizing hormone; polycystic ovary syndrome; restricted cubic spline; POLYCYSTIC-OVARY-SYNDROME; DOSE-RESPONSE ANALYSES; LUTEINIZING-HORMONE; PROGESTERONE; PREGNANCY;
D O I
10.1002/ijgo.15131
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to investigate the influence of ratio of serum luteinizing hormone (LH) on gonadotropin-releasing hormone antagonist (GnRH-ant) day to basal LH (hLH/bLH) on in-vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) outcome in polycystic ovary syndrome (PCOS) women who received GnRH-ant protocol for controlled ovarian hyperstimulation (COH).Methods: This retrospective study was conducted in women with PCOS (n = 1116) who underwent the GnRH-ant protocol for COH between 2015 and 2022 and were stratified as group A (hLH/bLH < 1, n = 489) and group B (hLH/bLH = 1, n = 627) according to the variation of serum LH. The outcomes of COH and the first frozen embryo transfer (FET) cycle were compared between group A, B and the linear relationship between hLH/bLH ratio and IVF/ICSI outcomes were studied by multivariate linear regression analysis and restricted cubic spline (RCS) models.Results: There were significant differences in baseline characteristics and outcomes between group A and B. Group A had higher levels of bLH, AMH, estradiol (E2) on GnRH-ant start day and lower levels of LH on GnRH-ant start day. Group B has better ovulation induction outcomes: more retrieved oocytes, normally fertilized oocytes (2PN), cleavage embryos, available embryos and high-quality blastocysts. Multivariate linear regression analysis found no statistically significant connection between hLH/bLH and clinical outcomes. RCS models showed hLH/bLH had nonlinear association with outcomes, including number of oocytes retrieved, 2PN, available embryos, incidence of OHSS, chemical pregnancy, clinical pregnancy, abortion and live birth.Conclusions: hLH/bLH ratio could be a more forward-looking indicator of clinical outcome in women with PCOS undergoing GnRH-ant protocols than LH on trigger day and the ratio of LH level on trigger day to basal LH. hLH/bLH = 1 may be the best condition for higher live birth rate and lower OHSS rate. LH on GnRH-ant day to basal LH could be an indicator of clinical outcome in women with PCOS undergoing GnRH-ant protocols.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 25 条
  • [1] Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome
    Bosch, E
    Valencia, W
    Escudero, E
    Crespo, J
    Simón, C
    Remohi, J
    Pellicer, A
    [J]. FERTILITY AND STERILITY, 2003, 80 (06) : 1444 - 1449
  • [2] ESHRE guideline:oval n s simulation for IVF/ICSI
    Bosch, Ernesto
    Broer, Simone
    Griesinger, Georg
    Grynberg, Michael
    Humaidan, Peter
    Kolibianakis, Estratios
    Kunicki, Michal
    La Marca, Antonio
    Lainas, George
    Le Clef, Nathalie
    Massin, Nathalie
    Mastenbroek, Sebastiaan
    Polyzos, Nikolaos
    Sunkara, Sesh Kamal
    Timeva, Tanya
    Toyli, Mira
    Urbancsek, Janos
    Vermeulen, Nathalie
    Broekmans, Frank
    [J]. HUMAN REPRODUCTION OPEN, 2020, 2020 (02)
  • [3] The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art
    Bruni, Vincenzina
    Capozzi, Anna
    Lello, Stefano
    [J]. REPRODUCTIVE SCIENCES, 2022, 29 (03) : 668 - 679
  • [4] GnRH antagonists for treatment of polycystic ovarian syndrome
    Cardone, VS
    [J]. FERTILITY AND STERILITY, 2003, 80 : S25 - S31
  • [5] GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
    Chaudhari, Nirja
    Dawalbhakta, Mitali
    Nampoothiri, Laxmipriya
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018, 16
  • [6] Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
    Chen, Qiuju
    Chai, Weiran
    Wang, Yun
    Cai, Renfei
    Zhang, Shaozhen
    Lu, Xuefeng
    Zeng, Xiaojing
    Sun, Lihua
    Kuang, Yanping
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [7] Dose-response analyses using restricted cubic spline functions in public health research
    Desquilbet, Loic
    Mariotti, Francois
    [J]. STATISTICS IN MEDICINE, 2010, 29 (09) : 1037 - 1057
  • [8] Deswal Ritu, 2020, J Hum Reprod Sci, V13, P261, DOI 10.4103/jhrs.JHRS_95_18
  • [9] Anti-Mullerian Hormone (AMH) May Stall Ovarian Cortex Function Through Modulation of Hormone Receptors Other Than the AMH Receptor
    Detti, Laura
    Fletcher, Nicole M.
    Saed, Ghassan M.
    Peregrin-Alvarez, Irene
    Uhlmann, Rebecca A.
    [J]. REPRODUCTIVE SCIENCES, 2018, 25 (08) : 1218 - 1223
  • [10] Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles
    Dovey, Serena
    McIntyre, Kerri
    Jacobson, Debbie
    Catov, Janet
    Wakim, Anthony
    [J]. FERTILITY AND STERILITY, 2011, 96 (03) : 585 - 589